Celgene, Novartis Settle With Barr Over Generic Ritalin
Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over the generic-drug maker's attempt to market its own version of blockbuster drug Ritalin, a treatment for attention...To view the full article, register now.
Already a subscriber? Click here to view full article